• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用定量聚合酶链反应(qPCR)和数字聚合酶链反应(dPCR)对基于腺病毒载体的疫苗进行方法验证以及生物分布和脱落评估。

Method validation and assessment of the biodistribution and shedding for adenovirus vector-based vaccine using qPCR and dPCR.

作者信息

Tanaka Yoichi, Hamano Sayaka, Ishii-Watabe Akiko, Saito Yoshiro, Kikura-Hanajiri Ruri

机构信息

Division of Medicinal Safety Science, National Institute of Health Sciences, Kanagawa 210-9501, Japan.

Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kanagawa 210-9501, Japan.

出版信息

Mol Ther Methods Clin Dev. 2025 Aug 5;33(3):101549. doi: 10.1016/j.omtm.2025.101549. eCollection 2025 Sep 11.

DOI:10.1016/j.omtm.2025.101549
PMID:40893162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12395528/
Abstract

Assessment of the biodistribution and shedding is required for the development of viral vector-based vaccines. Vector copy number is commonly quantified using digital PCR (dPCR) or quantitative PCR (qPCR). However, the regulatory guidelines for bioanalytical PCR assays have not been released at present. To consider the future setting of acceptance criteria for method validation in a guideline, we aimed to develop and validate a method for quantifying a model adenoviral (Ad) vector vaccine (Ad-hCovHKU1S-2A-GFP) using dPCR and qPCR in biological matrices and assessed its biodistribution in mice. Primers and probes were designed for the region between the sequences of the Ad and HKU1S. Method development and validation were performed using dPCR and qPCR with 1 μg of mouse genomic DNA (gDNA)/reaction. The validation parameters and their acceptance criteria were pre-defined as possible values referred from the literature. Lower limits of quantitation were set as 12 copies and 48 copies/reaction for dPCR and qPCR, respectively. Both dPCR and qPCR met the pre-defined acceptance criteria for intra- and inter-run accuracy and precision. Cross-validation showed similar quantitative results using both dPCR and qPCR. The pre-defined acceptance criteria on dPCR and qPCR may be applicable to the biodistribution and shedding of viral vector-based vaccines.

摘要

基于病毒载体的疫苗研发需要评估生物分布和脱落情况。载体拷贝数通常使用数字PCR(dPCR)或定量PCR(qPCR)进行定量。然而,目前生物分析PCR检测的监管指南尚未发布。为了在指南中考虑未来方法验证的验收标准设定,我们旨在开发并验证一种使用dPCR和qPCR在生物基质中定量模型腺病毒(Ad)载体疫苗(Ad-hCovHKU1S-2A-GFP)的方法,并评估其在小鼠体内的生物分布。针对Ad和HKU1S序列之间的区域设计了引物和探针。使用dPCR和qPCR,每个反应加入1μg小鼠基因组DNA(gDNA)进行方法开发和验证。验证参数及其验收标准预先定义为参考文献的可能值。dPCR和qPCR的定量下限分别设定为每个反应12拷贝和48拷贝。dPCR和qPCR均符合预先定义的批内和批间准确性及精密度验收标准。交叉验证表明,使用dPCR和qPCR得到的定量结果相似。dPCR和qPCR的预先定义验收标准可能适用于基于病毒载体的疫苗的生物分布和脱落情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f62/12395528/136ab9e23468/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f62/12395528/956938171651/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f62/12395528/d51092d096dc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f62/12395528/87ff899d2602/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f62/12395528/88c31afaf96f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f62/12395528/136ab9e23468/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f62/12395528/956938171651/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f62/12395528/d51092d096dc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f62/12395528/87ff899d2602/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f62/12395528/88c31afaf96f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f62/12395528/136ab9e23468/gr4.jpg

相似文献

1
Method validation and assessment of the biodistribution and shedding for adenovirus vector-based vaccine using qPCR and dPCR.使用定量聚合酶链反应(qPCR)和数字聚合酶链反应(dPCR)对基于腺病毒载体的疫苗进行方法验证以及生物分布和脱落评估。
Mol Ther Methods Clin Dev. 2025 Aug 5;33(3):101549. doi: 10.1016/j.omtm.2025.101549. eCollection 2025 Sep 11.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.
4
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
5
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
6
A New Measure of Quantified Social Health Is Associated With Levels of Discomfort, Capability, and Mental and General Health Among Patients Seeking Musculoskeletal Specialty Care.一种新的量化社会健康指标与寻求肌肉骨骼专科护理的患者的不适程度、能力以及心理和总体健康水平相关。
Clin Orthop Relat Res. 2025 Apr 1;483(4):647-663. doi: 10.1097/CORR.0000000000003394. Epub 2025 Feb 5.
7
Comparison of quantitative PCR and digital PCR assays for quantitative detection of infectious bronchitis virus (IBV) genome.比较定量 PCR 和数字 PCR 检测方法在传染性支气管炎病毒(IBV)基因组定量检测中的应用。
J Virol Methods. 2024 Feb;324:114859. doi: 10.1016/j.jviromet.2023.114859. Epub 2023 Dec 5.
8
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
9
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
10
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.马克 VCID 脑小血管联盟:一、入组、临床、液体方案。
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.

本文引用的文献

1
Recommendations for Method Development and Validation of qPCR and dPCR Assays in Support of Cell and Gene Therapy Drug Development.支持细胞和基因治疗药物开发的 qPCR 和 dPCR 分析方法开发和验证的建议。
AAPS J. 2024 Feb 5;26(1):24. doi: 10.1208/s12248-023-00880-9.
2
Development and validation of a model gene therapy biodistribution assay for AVGN7 using digital droplet polymerase chain reaction.使用数字液滴聚合酶链反应开发和验证用于AVGN7的模型基因治疗生物分布测定法。
Mol Ther Methods Clin Dev. 2023 May 10;29:494-503. doi: 10.1016/j.omtm.2023.05.007. eCollection 2023 Jun 8.
3
Quantitative polymerase chain reaction in the bioanalytical laboratory and technical and scientific considerations for nonclinical and clinical assay characterization, validation and sample analysis.
定量聚合酶链反应在生物分析实验室中的应用,以及非临床和临床分析方法特性描述、验证和样品分析的技术和科学考虑因素。
Bioanalysis. 2022 Aug;14(16):1085-1093. doi: 10.4155/bio-2022-0170. Epub 2022 Sep 20.
4
Recommendations on qPCR/ddPCR assay validation by GCC.GCC 关于 qPCR/ddPCR assay 验证的建议。
Bioanalysis. 2022 Jun;14(12):853-863. doi: 10.4155/bio-2022-0109. Epub 2022 Jun 15.
5
Non-clinical immunogenicity, biodistribution and toxicology evaluation of a chimpanzee adenovirus-based COVID-19 vaccine in rat and rhesus macaque.基于黑猩猩腺病毒的新冠疫苗在大鼠和恒河猴中的非临床免疫原性、生物分布及毒理学评价
Arch Toxicol. 2022 May;96(5):1437-1453. doi: 10.1007/s00204-021-03221-x. Epub 2022 Feb 28.
6
Best Practices in qPCR and dPCR Validation in Regulated Bioanalytical Laboratories.受监管生物分析实验室中qPCR和dPCR验证的最佳实践
AAPS J. 2022 Feb 22;24(2):36. doi: 10.1208/s12248-022-00686-1.
7
Biodistribution and immunity of adenovirus 5/35 and modified vaccinia Ankara vector vaccines against human immunodeficiency virus 1 clade C.5型/35型腺病毒及安卡拉痘苗病毒载体疫苗针对人类免疫缺陷病毒1型C亚型的生物分布与免疫性
Gene Ther. 2022 Nov;29(10-11):636-642. doi: 10.1038/s41434-021-00308-z. Epub 2022 Jan 6.
8
Adenovirus vector-based vaccine for infectious diseases.腺病毒载体疫苗用于传染病。
Drug Metab Pharmacokinet. 2022 Feb;42:100432. doi: 10.1016/j.dmpk.2021.100432. Epub 2021 Nov 12.
9
AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice.AZD1222(ChAdOx1 nCov-19):在小鼠中进行的单次剂量生物分布研究。
Vaccine. 2022 Jan 21;40(2):192-195. doi: 10.1016/j.vaccine.2021.11.028. Epub 2021 Dec 2.
10
Digital PCR to quantify ChAdOx1 nCoV-19 copies in blood and tissues.采用数字PCR技术定量检测血液和组织中ChAdOx1 nCoV-19病毒拷贝数。
Mol Ther Methods Clin Dev. 2021 Oct 16;23:418-423. doi: 10.1016/j.omtm.2021.10.002. eCollection 2021 Dec 10.